Aclaris Therapeutics Inc (NASDAQ:ACRS) currently has a daily average trading volume of 906.55K but it saw 1685546 shares traded in last market. With a market cap of 174.33M USD, the company’s current market price of $1.61 came rising about 9.52 while comparing to the previous closing price of $1.47. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.17 and as low as $0.99.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wedbush which initiated the stock as “Outperform” in its note to investors issued on May 28, 2025, recommending a price target of $8 for it. H.C. Wainwright issued its recommendations for the stock as it upgraded the price target for the stock is $20.
Over the week, ACRS’s stock price is moving 14.18% up while it is 25.78% when we observe its performance for the past one month. Year-to-date it is -35.08% down and over the past year, the stock is showing an upside performance of 56.31%.
Currently, Aclaris Therapeutics Inc’s total number of outstanding shares is 108.27M with 2.66% of that held by the insiders while 88.26% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -89.15% and return on equity (ROE) at -91.03%. Stock’s beta reads 0.42. Stock has a price to book (P/B) ratio of 1.21 while price to sale or P/S ratio amounts to 9.80. Its return on asset (ROA) is -69.97% on average.
